June 9, 2022 - Memorial Hermann Health System Joins Existing Investors in Leiters, a 503B Outsourced Pharmaceutical Compounding Industry Leader

DENVER – June 9, 2022 – Today Leiters has announced that Memorial Hermann Health System – a non-profit, community-focused, award-winning health system committed to creating healthier Houston communities – has joined the company’s growing list of strategic health system investor…

April 28, 2022 - Nevakar Injectables Receives U.S. FDA Approval of Ready-to-Use Ephedrine Injection in a Prefilled Syringe

BRIDGEWATER, NJ – April 28, 2022 – Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulatory care settings, and announced today that…

April 15, 2022 - Click Therapeutics Closes $15 Million Debt Financing from Silicon Valley Bank

NEW YORK – April 15, 2022 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that it has secured a $15 million term loan from Silicon Valley Bank. Proceeds from the financing were used in part to retire…

March 8, 2022 - On Target Laboratories and Mauna Kea Technologies Announce a Novel Clinical Research and Product Development Collaboration

PARIS & BOSTON – March 8, 2022 – On Target Laboratories, Inc. (‘On Target’) a privately-held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery and Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY)…

March 2, 2022 - H.I.G. Capital Expands BioHealth Team with Addition of Gwen Watanabe

STAMFORD – March 2, 2022 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with over $47 billion of equity capital under management, is pleased to announce that Gwen Watanabe has joined the firm’s dedicated life-science investment affiliate, H.I.G.…

February 8, 2022 - Leiters Announces Facility Acquisition to Increase Capacity, Accommodate Growth and Expand Portfolio

DENVER – February 8, 2022 – Leiters, a trusted FDA-registered 503B outsourcing provider of hospital and ophthalmology compounded sterile preparations announced today that it has completed the purchase of a new manufacturing facility in Buena, New Jersey. The 110,000 square foot…

January 18, 2022 - Augmented Reality Pioneer Augmedics Announces New CEO in Support of Accelerating Growth

CHICAGO – January 18, 2022 – Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced its newest executive leadership addition in support of the accelerating growth of the company’s revolutionary AR-driven xvision system®. The company announced the…